The 80th Annual Meeting of the Japanese Society of Hematology

Sessions

Industry Session

3 results  (1 - 3)

  • Industry Session

IS1-8

Targeting BCL2 to treat hematological cancers

Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Harumi Mukai (Hepatology & Oncology, Medical Affairs, Medical, AbbVie GK)

Sponsor: AbbVie GK

  • Industry Session

IS1-9

Perspectives on Making Clinical Evidence Using Real World Data

Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.9 (Osaka International Convention Center, 10F 1008)

Sponsor: Chugai Pharmaceutical Co., Ltd.

  • Industry Session

IS1-11

CLL treatment strategy and recent advances

Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Hiroaki Fujimori (Oncology Department, Medical Affairs Division, Janssen Pharmaceutical K.K.)

Sponsor: Janssen Pharmaceutical K.K.